Craft
  • Home
  •  / Dewpoint Therapeutics
Dewpoint Therapeutics

Dewpoint Therapeutics

Total Funding

$137 M

Dewpoint Therapeutics Summary

Company summary

Overview
Dewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services. It offers genetically linked condensatopathy discovery engines, machine-learning-based image analysis tools, engineered cell lines collection, condensate-direct medicinal chemistry, and other solutions. The company uses biomolecular condensates to develop drugs for neurodegeneration, cancer, inflammation, infectious diseases, metabolic diseases, and rare genetic disorders.
Type
Private
Status
Active
Founded
2018
HQ
Boston, MA, US | view all locations
Website
https://dewpointx.com
Cybersecurity rating
Sectors

Key people

  • Ameet Nathwani

    Ameet Nathwani, Chief Executive Officer and Board Member

  • Richard Young

    Richard Young, Scientific Founder

    • Regina Barzilay
    • Jürgen Eckhardt

    LocationsView all

    2 locations detected

    • Boston, MA HQ

      United States

      451 D St #104

    • Dresden, SN

      Germany

      Tatzberg 47

    Footer menu